UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SLC6A4 variation and citalopram response

American journal of medical genetics. Part B, Neuropsychiatric genetics, 2009-04, Vol.150B (3), p.341-351

2009

Volltextzugriff (PDF)

Factor structure and dimensionality of the two depression scales in STARD using level 1 datasets

Journal of affective disorders, 2011-08, Vol.132 (3), p.396-400

2011

Volltextzugriff (PDF)

Bupropion and Naltrexone in Methamphetamine Use Disorder

The New England journal of medicine, 2021-01, Vol.384 (2), p.140-153

2021

Volltextzugriff (PDF)

The identification, assessment and management of difficult-to-treat depression: An international consensus statement

Journal of affective disorders, 2020-04, Vol.267, p.264-282

2020

Volltextzugriff (PDF)

CO86 Comparing Factors Associated With First and Recurrent Psychiatric Hospitalizations in Adult Patients With Major Depressive Disorder Using Cox Proportional Hazard Model and Extensions

Value in health, 2023-12, Vol.26 (12), p.S29

2023

Volltextzugriff (PDF)

The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication

Molecular psychiatry, 2010-08, Vol.15 (8), p.856-867

2010

Volltextzugriff (PDF)

What predicts attrition in second step medication treatments for depression? A STAR⁎D report

Journal of affective disorders, 2008-03, Vol.107, p.S82-S83

2008

Volltextzugriff (PDF)

Clinical response to SSRIs relative to cognitive behavioral therapy in depression: a symptom‐specific approach

World psychiatry, 2022-02, Vol.21 (1), p.152-153

2022

Volltextzugriff (PDF)

Mood Disorders: Systematic Medication Management

1, 1997

Volltextzugriff (PDF)

3. Sequencing and combining treatments: can the art become a science?

Biological psychiatry (1969), 2000-04, Vol.47 (8), p.S1-S1

Rush, A.J.

2000

Volltextzugriff (PDF)

Psychometric evaluation of the PHQ-9 and the full and brief QIDS-SR in patients with depression

Neuroscience Applied, 2023, Vol.2, p.102620, Article 102620

2023

Volltextzugriff (PDF)

What predicts attrition in second step medication treatments for depression? A STARD report

Journal of affective disorders, 2008, Vol.107, p.S82-S83

2008

Volltextzugriff (PDF)

P.2.c.035 Research update from the latest STARD findings

European neuropsychopharmacology, 2006, Vol.16, p.S331-S332

2006

Volltextzugriff (PDF)

Immuno-metabolic depression features predicting antidepressant treatment outcomes: a pooled analysis of iSPOT-D, CO-MED, EMBARC and Genome-based therapeutic drugs for depression clinical trials

Neuroscience Applied, 2023, Vol.2, p.103342, Article 103342

2023

Volltextzugriff (PDF)

285. Effects of hydrocortisone on β-adrenoceptor coupling to GS protein in depression before and after treatment

Biological psychiatry (1969), 2000-04, Vol.47 (8), p.S86

2000

Volltextzugriff (PDF)

285. Effects of hydrocortisone on β-adrenoceptor coupling to G S protein in depression before and after treatment

Biological psychiatry (1969), 2000, Vol.47 (8), p.S86-S86

2000

Volltextzugriff (PDF)

The effect of lithium on the membrane molecular dynamics of normal human erythrocytes

Biological psychiatry (1969), 1987-07, Vol.22 (7), p.857-871

1987

Volltextzugriff (PDF)

P.1.185 Does pretreatment anxiety or insomnia predict acute response to bupropion SR?

European neuropsychopharmacology, 2003-10, Vol.13, p.S253-S253

2003

Volltextzugriff (PDF)

Effects of vagus nerve stimulation on sleep in depressed patients

European psychiatry, 2002-05, Vol.17, p.136-136

2002

Volltextzugriff (PDF)

Effects of VNS on regional cerebral blood flow in depressed subjects

European psychiatry, 2002-05, Vol.17, p.113-114

2002

Volltextzugriff (PDF)

6. An update on new somatic treatments for depression—ECT, TMS, VNS, DBS

Biological psychiatry (1969), 2000-04, Vol.47 (8), p.S2-S2

2000

Volltextzugriff (PDF)

Ethnic/racial comparisons in symptomatology in a large sample of patients with schizophrenia in Texas

Schizophrenia research, 2003-03, Vol.60 (1), p.14-14

2003

Volltextzugriff (PDF)

Clinical predictors of cognitive function change in schizophrenia

Schizophrenia research, 2003-03, Vol.60 (1), p.152-153

2003

Volltextzugriff (PDF)

Ketanserin binding characteristics to 5-HT2A receptor: Evidence for two binding subsites

Biological psychiatry (1969), 1996-04, Vol.39 (7), p.534

1996

Volltextzugriff (PDF)

Pretreatment anxiety does not predict response to bupropion sustained release or sertraline

European neuropsychopharmacology, 1999-09, Vol.9, p.233-233

1999

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Englisch
(99)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Life Sciences & Biomedicine
(23)
Humans
(16)
Biological And Medical Sciences
(13)
Female
(12)
Male
(12)
Psychiatry
(12)
Medical Sciences
(10)
Physical Sciences
(9)
Adult
(8)
Physics
(7)
Surgery
(7)
Middle Aged
(6)
Neurosciences & Neurology
(6)
Technology
(6)
Depression
(5)
Psychology. Psychoanalysis. Psychiatry
(5)
Psychopathology. Psychiatry
(5)
Transplantation
(5)
Aged
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SLC6A4 variation and citalopram response

Factor structure and dimensionality of the two depression scales in STARD using level 1 datasets

Bupropion and Naltrexone in Methamphetamine Use Disorder

The identification, assessment and management of difficult-to-treat depression: An international consensus statement

CO86 Comparing Factors Associated With First and Recurrent Psychiatric Hospitalizations in Adult Patients With Major Depressive Disorder Using Cox Proportional Hazard Model and Extensions

The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication

What predicts attrition in second step medication treatments for depression? A STAR⁎D report

Clinical response to SSRIs relative to cognitive behavioral therapy in depression: a symptom‐specific approach

Mood Disorders: Systematic Medication Management

3. Sequencing and combining treatments: can the art become a science?

Psychometric evaluation of the PHQ-9 and the full and brief QIDS-SR in patients with depression

What predicts attrition in second step medication treatments for depression? A STARD report

P.2.c.035 Research update from the latest STARD findings

Immuno-metabolic depression features predicting antidepressant treatment outcomes: a pooled analysis of iSPOT-D, CO-MED, EMBARC and Genome-based therapeutic drugs for depression clinical trials

285. Effects of hydrocortisone on β-adrenoceptor coupling to GS protein in depression before and after treatment

285. Effects of hydrocortisone on β-adrenoceptor coupling to G S protein in depression before and after treatment

The effect of lithium on the membrane molecular dynamics of normal human erythrocytes

P.1.185 Does pretreatment anxiety or insomnia predict acute response to bupropion SR?

Effects of vagus nerve stimulation on sleep in depressed patients

Effects of VNS on regional cerebral blood flow in depressed subjects

6. An update on new somatic treatments for depression—ECT, TMS, VNS, DBS

Ethnic/racial comparisons in symptomatology in a large sample of patients with schizophrenia in Texas

Clinical predictors of cognitive function change in schizophrenia

Ketanserin binding characteristics to 5-HT2A receptor: Evidence for two binding subsites

Pretreatment anxiety does not predict response to bupropion sustained release or sertraline

Suchergebnisse filtern